4D Molecular Therapeutics, Inc. (FDMT)
10.80
-1.05
(-8.86%)
USD |
NASDAQ |
Oct 23, 16:00
10.78
-0.02
(-0.23%)
After-Hours: 20:00
4D Molecular Therapeutics EPS Diluted (Quarterly) : -1.038 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.038 |
| March 31, 2026 | -1.010 |
| December 31, 2025 | 0.3367 |
| September 30, 2025 | -1.013 |
| June 30, 2025 | -0.9773 |
| March 31, 2025 | -0.8606 |
| December 31, 2024 | -1.085 |
| September 30, 2024 | -0.7892 |
| June 30, 2024 | -0.6323 |
| March 31, 2024 | -0.6576 |
| September 30, 2023 | -0.2427 |
| June 30, 2023 | -0.7726 |
| March 31, 2023 | -0.8765 |
| Date | Value |
|---|---|
| December 31, 2022 | -0.8428 |
| September 30, 2022 | -0.7933 |
| June 30, 2022 | -0.8689 |
| March 31, 2022 | -0.8171 |
| December 31, 2021 | -0.8478 |
| September 30, 2021 | -0.823 |
| June 30, 2021 | -0.2838 |
| March 31, 2021 | -0.6147 |
| September 30, 2020 | -0.2936 |
| June 30, 2020 | -0.572 |
| March 31, 2020 | -0.4967 |
| December 31, 2019 | -0.6083 |
| September 30, 2019 | -0.6294 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agenus, Inc. | -0.0146 |
| Amgen, Inc. | 4.366 |
| Anika Therapeutics, Inc. | 0.2412 |
| BioCryst Pharmaceuticals, Inc. | 0.2957 |
| Imunon, Inc. | -0.5412 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -72.94M |
| Revenue (Quarterly) | 3.781M |
| Total Expenses (Quarterly) | 76.72M |
| Enterprise Value | 274.20M |
| Gross Profit Margin (Quarterly) | 44.75% |
| Profit Margin (Quarterly) | -1.93K% |
| Earnings Yield | -25.23% |
| Normalized Earnings Yield | -25.23 |